SAN FRANCISCO, Sept. 6, 2016 /PRNewswire/ -- Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis on silicon, today announced it has expanded its management team with the appointment of industry veterans Paula Green as vice president of human resources and Mark Daniels as general counsel.
“The expansion of our leadership team aligns with the advancement of our commercial organization as we work to scale our high throughput silicon platform to manufacture industry-leading volumes of synthetic DNA and genes,” commented Emily M. Leproust, Ph.D., CEO of Twist Bioscience. “Paula’s broad human resources experience and proven track record in building and fostering a high-impact innovative corporate culture make her an ideal fit to lead the growth and development of our employee base. Mark’s extensive legal expertise and deep knowledge of the biotechnology industry will bring important perspectives as we build vertical market opportunities for synthetic DNA.”
Paula Green brings over 20 years of global human resources experience and a track record of developing and delivering high-impact people strategies, solutions, processes and tools to empower a high performing organization. Prior to Twist Bioscience, she served as vice president of global human resources at QIAGEN, where she oversaw 50 human resources professionals supporting 3,900 employees through mergers, acquisitions, restructurings and other pivotal corporate transactions. Before QIAGEN, she was the human resources manager for Operon Technologies where her responsibilities included creating strategy, overseeing benefits for all employees, and delivering training, recruitment and retention programs. She also worked as a consultant for the Federal Home Loan Bank of San Francisco. Paula holds a B.S. in Organizational Behavior from the University of San Francisco.
Mark Daniels brings more than 25 years of experience as a seasoned legal officer with extensive technology and biotechnology industry expertise at Fortune 500 companies. Prior to joining Twist Bioscience, Mark was vice president, Law and deputy chief corporate compliance officer at Broadcom in Irvine, California. Before that, he spent 20 years in positions of increasing responsibility in the legal department at Amgen, where his last role was vice president and associate general counsel. Mark’s law firm experience includes time at Irell & Manella in Century City, California, and Cahill Gordon & Reindel and Skadden Arps in Manhattan. Mark was a law clerk to Judge Dickran Tevrizian (ret.) on the Federal District Court in Los Angeles. He served as an adjunct professor of Law at Pepperdine University School of Law in Malibu, California where he taught Food and Drug Law. Mark received his J.D., cum laude, from Harvard Law School, and his B.S. with honors from Cornell University.
About Twist Bioscience
At Twist Bioscience, our expertise is accelerating science and innovation by leveraging the power of scale. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well high throughput silicon platform capable of producing synthetic biology tools, including genes, oligonucleotide pools and variant libraries. By synthesizing DNA on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic DNA production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production, which in turn, expedites the design, build, test cycle to enable personalized medicines, pharmaceuticals, sustainable chemical production, improved agriculture production, diagnostics, biodetection and data storage. For more information, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.
Logo - http://photos.prnewswire.com/prnh/20160531/373930LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/twist-bioscience-bolsters-executive-leadership-team-300322505.html
SOURCE Twist Bioscience
